Phreesia (PHR) Revenue & Revenue Breakdown
Phreesia Revenue Highlights
Latest Revenue (Y)
$419.81M
Latest Revenue (Q)
$117.25M
Main Segment (Y)
Subscription And Services
Phreesia Revenue by Period
Phreesia Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-01-31 | $419.81M | 17.83% |
| 2024-01-31 | $356.30M | 26.84% |
| 2023-01-31 | $280.91M | 31.74% |
| 2022-01-31 | $213.23M | 43.42% |
| 2021-01-31 | $148.68M | 19.15% |
| 2020-01-31 | $124.78M | 24.92% |
| 2019-01-31 | $99.89M | 25.12% |
| 2018-01-31 | $79.83M | - |
Phreesia generated $419.81M in revenue during NA 2025, up 17.83% compared to the previous quarter, and up 336.43% compared to the same period a year ago.
Phreesia Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-07-31 | $117.25M | 1.14% |
| 2025-04-30 | $115.94M | 5.70% |
| 2025-01-31 | $109.68M | 2.70% |
| 2024-10-31 | $106.80M | 4.59% |
| 2024-07-31 | $102.11M | 0.89% |
| 2024-04-30 | $101.22M | 6.54% |
| 2024-01-31 | $95.00M | 3.70% |
| 2023-10-31 | $91.62M | 6.74% |
| 2023-07-31 | $85.83M | 2.37% |
| 2023-04-30 | $83.84M | 9.48% |
| 2023-01-31 | $76.59M | 4.76% |
| 2022-10-31 | $73.10M | 7.72% |
| 2022-07-31 | $67.87M | 7.12% |
| 2022-04-30 | $63.35M | 9.19% |
| 2022-01-31 | $58.02M | 3.76% |
| 2021-10-31 | $55.91M | 9.62% |
| 2021-07-31 | $51.01M | 5.62% |
| 2021-04-30 | $48.29M | 15.51% |
| 2021-01-31 | $41.81M | 8.69% |
| 2020-10-31 | $38.46M | 9.87% |
| 2020-07-31 | $35.01M | 4.83% |
| 2020-04-30 | $33.40M | 1.77% |
| 2020-01-31 | $32.81M | -0.09% |
| 2019-10-31 | $32.84M | 6.58% |
| 2019-07-31 | $30.82M | 8.85% |
| 2019-04-30 | $28.31M | 6.90% |
| 2019-01-31 | $26.48M | 6.98% |
| 2018-10-31 | $24.76M | -0.09% |
| 2018-07-31 | $24.78M | 3.80% |
| 2018-04-30 | $23.87M | - |
Phreesia generated $117.25M in revenue during Q2 2026, up 1.14% compared to the previous quarter, and up 115.85% compared to the same period a year ago.
Phreesia Revenue Breakdown
Phreesia Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Jan 25 | Jan 24 | Jan 23 | Jan 22 | Jan 21 |
|---|---|---|---|---|---|
| Subscription And Services | $196.51M | $165.44M | $128.97M | $95.51M | $69.04M |
| Network Solutions | $121.56M | $96.25M | $73.57M | - | - |
| Payment Processing Fees | $101.74M | $94.61M | $78.37M | $65.20M | $49.90M |
| Life Sciences | - | - | - | $52.52M | $29.73M |
Phreesia's latest annual revenue breakdown by segment (product or service), as of Jan 25: Subscription And Services (46.81%), Network Solutions (28.96%), and Payment Processing Fees (24.23%).
Quarterly Revenue by Product
| Product/Service | Jul 25 | Jan 25 | Oct 24 | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Jul 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Network Solutions | $35.16M | $33.21M | $32.73M | $28.20M | $27.41M | $25.84M | $25.81M | $22.90M | $21.70M | $20.99M | $20.48M | - | - | - | - | - | - | - | - | - |
| Payment Processing Fees | $28.39M | $24.68M | $24.70M | $25.30M | $27.06M | $23.51M | $23.22M | $23.63M | $24.25M | $19.78M | $19.63M | $19.58M | $19.38M | $16.14M | $16.11M | $16.31M | $16.64M | $13.45M | $12.92M | $11.83M |
| Subscription And Services | $53.70M | $51.79M | $49.36M | $48.61M | $46.74M | $45.65M | $42.59M | $39.30M | $37.89M | $35.81M | $32.99M | $31.07M | $29.10M | $26.45M | $24.36M | $22.89M | $21.82M | $18.85M | $17.47M | $17.13M |
| Life Sciences | - | - | - | - | - | - | - | - | - | - | - | $17.22M | $14.87M | $15.44M | $15.44M | $11.82M | $9.83M | $9.51M | $8.08M | $6.05M |
Phreesia's latest quarterly revenue breakdown by segment (product or service), as of Jul 25: Subscription And Services (45.80%), Network Solutions (29.99%), and Payment Processing Fees (24.21%).
Phreesia Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Jul 20 | Apr 20 | Jan 20 | Oct 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payment Processing Fees | $19.78M | $19.63M | $19.58M | $19.38M | $16.14M | $16.11M | $16.31M | $16.64M | $13.45M | $12.92M | $11.83M | $11.71M | $11.72M | $11.56M |
| Subscription And Services | $35.81M | $32.99M | $31.07M | $29.10M | $26.45M | $24.36M | $22.89M | $21.82M | $18.85M | $17.47M | $17.13M | $15.60M | - | - |
| Network Solutions | $20.99M | $20.48M | - | - | - | - | - | - | - | - | - | - | - | - |
| Life Sciences | - | - | $17.22M | $14.87M | $15.44M | $15.44M | $11.82M | $9.83M | $9.51M | $8.08M | $6.05M | $6.09M | $6.03M | $6.68M |
| Subscription And Related Services | - | - | - | - | - | - | - | - | - | - | - | - | - | $14.61M |
Phreesia's latest quarterly revenue breakdown by geography, as of Jan 23: Subscription And Services (46.76%), Network Solutions (27.41%), and Payment Processing Fees (25.83%).
Phreesia Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TDOC | Teladoc Health | $2.57B | $631.90M |
| CLOV | Clover Health Investments | $1.37B | $477.62M |
| OMCL | Omnicell | $1.11B | $290.56M |
| GDRX | GoodRx | $792.32M | $202.97M |
| TXG | 10x Genomics | $610.78M | $154.88M |
| BCRX | BioCryst Pharmaceuticals | $450.71M | $163.35M |
| PHR | Phreesia | $419.81M | $117.25M |
| SDGR | Schrödinger | $207.54M | $59.55M |
| OMDA | Omada Health | $169.80M | $54.96M |
| XERS | Xeris Biopharma | $163.91M | $71.54M |
| BLFS | BioLife Solutions | $82.25M | $23.94M |